Raphidiopsis brookii
Ontology highlight
ABSTRACT:
PROVIDER: PRJNA40121 | ENA |
REPOSITORIES: ENA
Similar Datasets
Project description:Microcystin-producing cyanobacterium
| PRJNA30803 | ENA
Project description:Shiga toxin-producing Escherichia coli phylogenetics
| PRJNA624229 | ENA
Project description:Isolated from a toxin-producing dinoflagellate
| PRJNA19279 | ENA
Project description:Shiga-toxin producing Enterotoxigenic Escherichia coli
| PRJEB25657 | ENA
Project description:Shiga toxin-producing Escherichia coli genome sequencing
| PRJNA383591 | ENA
Project description:Group A Streptococcus (GAS) is one of the world’s most successful pathogens, causing a multitude of common infections such as pharyngitis, cellulitis, and impetigo. It is also responsible for more severe diseases such as rheumatic fever, necrotizing fasciitis, and toxic shock syndrome. Group A Streptococcus produces a powerful peptide toxin known as streptolysin S (SLS). Although recent advances have begun to uncover the structure of SLS, many questions remain as to its route of synthesis, export and function. A fundamental yet unanswered question about SLS is the mechanism employed by GAS to resist the effects of its own toxin. To address this question, we developed a unique microarray-based approach aimed at identifying bacterial genes involved in SLS immunity. We measured changes in gene expression in a non-SLS producing GAS strain (∆SLS) after exposure to active SLS, as well as to an inactive SLS isoform. Initial exposure of a non-SLS producing GAS to the native SLS toxin resulted in significant upregulation of several gene candidates. Proteins encoded by these gene candidates were produced and tested for their ability to neutralize SLS toxin activity in vitro. The protein encoded by the gene Spy_0787 decreased the cytolytic activity of wt SLS by 50%. Bacterial immunity is still a relatively unknown and unexplained phenomena. Insights into how toxin-producing microorganisms achieve resistance against the effects of their own toxin could uncover important therapeutic targets to neutralize virulence factors such as SLS, as well as other related peptide toxins. The microarray technique described here can be leveraged to other microbial systems to understand how microorganisms in general react to antibacterial and cytotoxic compounds for which the mechanism of action is unknown.
2013-09-01 | GSE48775 | GEO